The Catch & Kill Approach: A New Model for Innovation Evaluation

The phrase "Catch & Kill" comes from a different industry, but it describes the operational shift that academic commercialization needs more precisely than any term we could invent.

In the original sense — borrowed from publishing — it referred to acquiring a story specifically to prevent it from being published elsewhere. We use it differently. In Vainture, every idea is "caught" by the same evaluation pipeline, scored across the same dimensions, and either killed early with a clear, evidence-based explanation, or advanced to the small set of opportunities that warrant institutional investment.

The asymmetry is intentional. We expect most ideas to die. That is the point.

Why traditional evaluation says yes too often

The default mode of innovation evaluation — at incubators, at tech transfer offices, at most early-stage venture funds — is biased toward advancement. The reasons are structural rather than malicious.

Evaluators have relationship costs. A tech transfer analyst who tells a faculty inventor "we don't think this is commercially viable" pays a relationship cost that the inventor remembers for years. The path of least resistance is to keep the disclosure open, file a provisional patent, and let the idea slowly die from neglect rather than from explicit rejection.

Incubators have program completion incentives. A 12-week accelerator with a 20-company cohort needs to fill those seats. The selection process becomes "best of the applicants we received" rather than "objectively meets the threshold." Companies advance because they applied, not because they should.

Investors have FOMO costs. Saying no to an idea that later succeeds is a more painful career outcome than saying yes to an idea that later fails — particularly at the seed stage where check sizes are small and portfolio diversification absorbs individual losses. The asymmetry pushes evaluators toward the soft yes.

Inventors are persuasive. Faculty researchers are by definition trained to make compelling arguments for their work. An evaluator without independent evidence almost always defers to the inventor's framing, which is invariably more optimistic than the realistic commercial picture.

The cumulative effect is that most evaluation processes act as a low-pass filter on optimism. Ideas that should have been killed at week one persist for years.

What Catch & Kill changes

The Catch & Kill methodology inverts three things about traditional evaluation.

It evaluates everything to the same depth. Every idea — strong, weak, ambiguous — runs through the same six-dimensional analysis: market opportunity, competitive landscape, regulatory pathway, investor landscape, strategic partner fit, public funding availability. There is no triage by intuition before the analysis happens. The analysis itself is the triage.

It defaults to no. A score below the threshold receives an explicit kill recommendation with specific reasons: this competitor is already in Phase III, this market is smaller than the inventor assumed, this regulatory pathway will require capital the spinout cannot raise. The kill is not a polite shelving. It is a documented decision.

It uses real evidence at every step. The named competitors are real companies with real recent activity. The named investors have made real recent investments in comparable opportunities. The named funding programs have real award amounts and real deadlines. The analysis can be audited end-to-end. There is no "the market opportunity is significant" — there is "the addressable U.S. patient population is approximately 47,000 with a current standard-of-care annual cost of $X."

This shift produces three institutional benefits.

The first benefit: bandwidth

When most ideas are killed within minutes of submission, the institutional commercialization team can focus its scarce attention on the few opportunities that warrant deep human engagement. Instead of skimming 150 disclosures per year and missing the good ones, the team works seriously on the 15 that survive Catch & Kill.

This is not a story about replacing human judgment. It is a story about clearing the queue so that human judgment can be applied where it matters most.

The second benefit: investor confidence

Opportunities that emerge from Catch & Kill arrive at the investor with a structured pre-evaluation that addresses every question a competent investor would ask. Market size is sourced. Competitors are named. Regulatory pathway is mapped. Comparable financing rounds are documented. The investor still does their own diligence, but the evidence base is already assembled.

This shortens diligence cycles. It increases conversion. And — perhaps most importantly — it allows philanthropic and institutional funds to underwrite earlier-stage opportunities than they could before, because the pre-evaluation reduces the unknowns that make early-stage capital so risky.

The third benefit: inventor honesty

The least-discussed benefit of Catch & Kill is the effect on the inventor relationship. A faculty researcher who receives an honest, evidence-based "no" at week one has a better experience than the same researcher who spends three years on a slow path to nowhere.

The honest no preserves the inventor's time, preserves the institution's credibility, and — counterintuitively — preserves the relationship. Researchers respect rigor. They lose respect for processes that drag on without resolution.

What it does not do

Catch & Kill is not infallible. It will occasionally kill an idea that, with different timing or a different team, could have succeeded. It will occasionally advance an idea that, on closer human inspection, has fatal problems the AI did not surface.

We accept these errors deliberately. The cost of false positives in the current system — ideas that advance, consume capital, and fail late — is far higher than the cost of false negatives in the new system. An idea killed at week one can be revisited later with new evidence. An idea that consumes a year of inventor time and a million dollars of pilot capital before failing cannot.

The operational shift

Catch & Kill is, fundamentally, a shift from a process that defaults to advancement to a process that defaults to rigorous skepticism. It moves the burden of proof from the evaluator (who must justify a no) to the idea itself (which must clear a structured threshold across six dimensions).

This is uncomfortable for institutions accustomed to the old model. It produces fewer "in flight" projects. It generates fewer easy yes conversations. It requires evaluators to accept that most ideas — including ideas from senior, well-respected researchers — will not advance.

The institutions that adopt this model produce smaller, sharper portfolios with measurably higher commercialization rates. The ones that do not continue the pattern of slow attrition that defines the current state of academic commercialization.

We built Vainture for the former.